De SOUZA, M. M.; CRUZ, A. B.; SCHUHMACHER, M. B.; KREUGER, M. R.; FREITAS, R. A.;
CRUZ, R. C. B. Métodos de avaliação de atividade biológica de produtos naturais e sintéticos. In:
BRESOLIN, T. M. B.; CECHINEL FILHO, V. (organizadores). Ciências Farmacêuticas.
Contribuição ao desenvolvimento de novos fármacos e medicamentos. Itajaí: Editora UNIVALI,
2003, cap. 3, p. 108-166.
DEMEHRI, S.; HOMAYOUN, H.; HONAR, H.; RIAZI, K.; VAFAIE, K.; ROUSHANZAMIR, F.;
DEHPOUR, A. R. Agmatine exerts anticonvulsivant effect in mice: modulation by alpha 2-
adrenoceptors and nitric oxide. Neuropharmac., v. 45, p. 534-542, 2003.
D’SA, C.; DUMAN, R. S. Antidepressants and neuroplasticity. Bip. Disord., v. 4, p. 183-194, 2002.
DUMAN, R. S. NAKAGAWA, S.; MALBERG, J. Regulation of adult neurogenesis by
antidepressant. Neuropsychophar., v. 25, p.. 836-844, 2001.
DUMAN, R. S.; MALBERG,, J.; NAKAGAWA, S.; D’SA, C. M. Neural plasticity and surviral in
mood disorders. Biol. Psychiatry, v. 48, p. 732-739, 2000.
DUNN, R. W.; REED, T. A.; COPELAND, P. D.; FRYE, C. A. The nitric oxide synthase inhibitor 7-
nitroindaazole displays enhanced anxiolyytic efficacy without tolerance in rats following subchronic
administration. Neuropharmacol., v. 37, p. 899—904, 1998.
FARIA, M. S.; MUSCARA, M. N.; MORENO JÚNIOR, H.; TEIXEIRA, S. A.; DIAS, H. B.; De
OLIVEIRA, B. Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test. Eur.
J. Pharmacol., v. 23, p. 37-43, 1997.
FENG, Y.; HALARIS, A. E.; PILETZ, J. E. Determination of agmatine in brain and plasma using
high-performance liquid chromatography with fluorescence detection. J. Chromatogr., v. 691, p. 177-
286, 1997.
FENG, Y.; PILETZ, J. E.; LEBLANC, M. H. Agmatine supresses nitric oxide production and
attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr. Res., v. 52, p. 606-611, 2002.
FILE, S. Animal tests of anxiety. Curr. Protoc. in Neurosci., v. 8, p. 1-8, 1997.
FRAZER, A. Pharmacology of antidepressant. J. Clin. Psychopharmacol., v. 17, p. 2S-18S, 1997.
GALEA, E.; REGUNATHAN, S.; ELIOPOULOS, V.; FEINSTEIN, D. L.; REIS, D. J. Inhibition of
mammalian nitric oxide synthase by agmatine, an endogenous polyamine formed by decarboxylation
of arginine. J. Biochem., v. 316, p. 247-49, 1996.
GAO, Y.; GUMUSEL, B.; KOVES, G.; PRASAD, A.; HAO, Q.; HYMAN, A.; LIPPTON, H.
Agmatine: a novel endogenous vasodilator substance. Life Science., v. 57, p. 83-86, 1995.
GARCIA-SEVILLA, J. A.; ESCRIBA, P. V.; WALZER, C.; BOURAS, C.; GUIMON, J. Imidazoline
receptor proteins in brain of patients with Alzheimer’s disease. Neurosci. Letter, v. 247, p. 95-98,
1998.
GARCIA-SEVILLA, J. A.; ESCRIBA, P. V.; GUIMON, J. Imidazoline receptors and human brain
disorders. Ann. N. Y. Acad. Science, v. 881, p. 392-409, 1999.
GIBSON, D.; HARRIS, B.; ROGERS, D.; LITTLETON, J. Radioligand binding studies reveal
agmatine is more seletive antagonist for a polyamine-site on the NMDA receptor than arcaine or
ifenprodil. Brain Res., v. 71, p. 952, 2002.